Ethan Joseph, MD
Internal Medicine · Charleston, SCNPI 1184281859
Payments from drug & device makers
Across 72 payments — averaging $96.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- AbbVie$1K
- NEW World Medical,inc.$800
- Johnson & Johnson Surgical Vision, Inc.$588
- Glaukos Corporation$449
- Bausch & Lomb Americas Inc.$346
- plus $2K from 14 others
What the payments were for
- Food & beverage$6,81499%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 16 | $1,528 |
| AbbVie | 14 | $1,088 |
| NEW World Medical,inc. | 1 | $800 |
| Johnson & Johnson Surgical Vision, Inc. | 12 | $588 |
| Glaukos Corporation | 4 | $449 |
| Bausch & Lomb Americas Inc. | 4 | $346 |
| Sight Sciences, Inc. | 4 | $279 |
| Carl Zeiss Meditec USA, Inc. | 2 | $253 |
| Dompe US, Inc. | 3 | $248 |
| Amgen | 1 | $168 |
| Biotissue Holdings Inc. | 1 | $161 |
| Tarsus Pharmaceuticals, Inc. | 2 | $152 |
| Genentech, Inc. | 1 | $137 |
| Recordati_rare_diseases_inc. | 1 | $124 |
| Harrow Eye, LLC | 1 | $122 |
| Axogen | 1 | $121 |
| Sun Pharmaceutical Industries Inc. | 1 | $119 |
| Regeneron Healthcare Solutions, Inc. | 1 | $114 |
| Astellas Pharma US Inc | 1 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Clareon$697
- XEN GLAUCOMA TREATMENT SYSTEM$486
- iDose$302
- Oxervate$222
- TEPEZZA$168
- QUATERA 700$156
- Hydrus Microstent$149
- OMNI(R) SURGICAL SYSTEM (US)$149
- Unity$148
- NGENUITY$147
- VABYSMO$137
- ARGOS$129
- CYSTADROPS$124
- enVista MX60 IOL$124
- DURYSTA$122
- Clareon PanOptix Pro$122
- Flarex$122
- IHEEZO$122
- Verkazia$122
- Tobradex ST$122
How this compares
$6,914 in reported general payments places this provider in the 90th percentile of 1,498 internal medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 16 | $159 |
| Atorvastatin Calcium | 11 | $64 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Charleston
- Jan BasileCharleston$278K
- James ThomasCharleston$154K
- John CleekCharleston$136K
- Shakaib RehmanCharleston$94K
- Leonard AlsfeldCharleston$91K
- Samuel Schumann IiiCharleston$48K
- Brett TomashitisCharleston$36K
- Scott SandsCharleston$25K
- Laura KinneyCharleston$20K
- Andrew SchreinerCharleston$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.